The Funding Tool Box

Duke has a wealth of funding options available to help get your idea off the ground and into the market. Below you'll find some resources to get you on your way.

CTSI Funding Opportunities

The Duke CTSI supports translational research, from discovery to preclinical and human trials, and on to implementation into practice or commercialization.  Duke CTSI accelerates translational research not only by providing funding, but also by promoting investigator collaboration, encouraging innovation, providing project management assistance, and providing access to resources/services in a collaborative and service-oriented fashion

The CTSI supports the development of novel methods and proof of concept evaluation of therapeutic agents, biomedical devices, diagnostic tests, and technologies through various funding opportunities.

CTSI Population Health Improvement Awards

  • Three-tiered program with awards from $1,000 to $25,000
  • Purpose: Seed, Co-development, and Advanced Partnership Awards to stimulate and foster community-research partnerships that advance solutions to improve local health and healthcare delivery.
  • Status:  2017-18 application period ended March 29, 2017. Next application period will open in spring of 2018.

CTSI Translational Accelerator Funding Agreements

  • up to $150,000
  • Purpose: Support for cross-disciplinary scientific research addressing the development of therapies, diagnostics or devices applicable to human disease, clinical research/trials (excluding Phase 2 or beyond), epidemiological studies, and/or community-based research.
  • Status: Application deadline is November 6, 2017.

CTSI Transformative Research Agreements

  • up to $500,000
  • Purpose: Support development of mature research with the potential to attract significant interest for external partnering, thus enabling and accelerating translation of research out of the academic environment (i.e. new company formation, license, or partnership).
  • Status: 2018-2020 cycle deadline is November 6, 2017

Duke/UNC-Chapel Hill CTSA Consortium Collaborative

  • $25,000 per institution ($50,000 total)
  • Purpose: Develop inter-institutional collaborations for new investigator teams conducting novel clinical and translational research that applies or accelerates discovery into testing in clinical or population settings.
  • Status:The 2018-2019 application deadline is October 5, 2017

Duke/NC State Translational Research Grant

  • up to $25,000 per institution ($50,000 total)
  • Purpose: Develop inter-institutional collaborations for new investigator teams conducting novel clinical and translational research that applies or accelerates discovery into testing in clinical or population settings.
  • Status: Next application period will open spring of 2018

Carolinas Collaborative

  • $25,000 per institution
  • Purpose: CTSAs at Duke, the Medical University of South Carolina, UNC-CH, and Wake Forest, have partnered with Health Sciences South Carolina to create a pilot program designed to encourage and facilitate novel clinical and translational research that applies or accelerates discovery into testing in clinical or population settings. The research must use the component electronic health record data warehouses from at least two of the four CTSAs.
  • Status: Next application period is TBA

Duke-Coulter Translational Partnership Grants(link is external)

  • No fixed award limit.  Approximately $700,000 is available annually to fund ~3-5 projects
  • Purpose: Support collaborative translational research projects that involve co-investigators from the Duke University Department of Biomedical Engineering and a clinical department in the Duke University Health System.
  • Status: Next application deadline is March 9, 2018
  • View the 2017-2018 RFA(link is external)

FAQs for Pilot Program Funding

View Past Award Winners

The CTSI Pilot Programs are funded primarily through Duke’s National Institutes of Health (NIH), National Center for Advancing Translational Sciences (NCATS) Clinical and Translational Science Award (CTSA) UL1TR001117.

Coulter Translational Partnership (TP) & Research Awards (CTRA)

To benefit mankind, innovations born in the academic environment must be translated to practical use. However, in the late 90s, there were no standardized processes, defined organization or consistent funding sources to help translate academic biomedical innovations from the bench to the bedside. This is the environment that the Wallace H. Coulter Foundation encountered when it began its translational research program in 2001. The Foundation successfully transformed Wallace Coulter’s philosophy of “science serving humanity” into these pioneering programs, capitalizing on the best aspects of academia and industry, which were able to attract necessary funding sources to create products that help patients.

Coulter Translational Research Partnership Award in Biomedical Engineering (TP)

Coulter Translational Research Partnership Award in Biomedical Engineering (TP)

The Biomedical Engineering Department Chair is considered the Principle Investigator of the award. Each school established an Oversight Committee, consisting of stake holders in the translational process. Additionally, the grant also provided funding for a Coulter Project Director to oversee the daily operations of the award. This Award provided $1MM each year for a period of five years.

READ MORE

Coulter Translational Research Award (CTRA)

In 2005, the Foundation launched the “Early Career” (EC) program which later was rebranded as the “Coulter Translational Research Award” (CTRA) program. The Coulter Translational Research Awards provided funding for individual Professors in established Biomedical Engineering Departments within the United States, rather than at the department level. The awards support biomedical research that is translational in nature, to encourage and assist eligible biomedical engineering investigators to establish themselves in academic careers involving translational research.

READ MORE

Duke's Innovation & Entrepreneurship Initiative

Duke hosts a curated Partner Page on Indiegogo, the leading crowdfunding site for research and education based ventures.  Students, faculty, and alumni of Duke can use the site to showcase their work and seek contributions to advance their program.  If you’re interested, contact us at: entrepreneurship@duke.edu.

Learn More

Twice a year, six startups founded by Duke alumni or students are selected to pitch to a panel of Duke investors. Apply to present your company, or RSVP to see the latest Duke startups, learn about entrepreneurship, and meet fellow entrepreneurs.

Learn More

For multidisciplinary teams of students, faculty, and industry mentors.  Earn up to $75,000 to develop a technology into a business.

Learn More

NC IDEA provides grants of up to $50k to fund business activities that validate potential markets, reduce business risks, and advance projects to the point at which they are suitable for private equity investment.

Learn More

IFNC makes pre-seed funding awards to help entrepreneurs validate their technologies and business concepts. In addition to funding, IFNC provides education and mentoring resources to all awardees.

Learn More

Check-out this list of funds and angels with ties to Duke University.  Compiled by DukeGEN.

Learn More

Grants and Programs for Faculty Entrepreneurs

Programs to support translational research available to Duke faculty

Learn More

Duke Institute for Health Innovation (DIHI)

The mission of the Duke Institute for Health Innovation (DIHI) is to promote transformative innovation in health and healthcare, and to help cultivate a community of entrepreneurship across Duke University and its health enterprise.  Our annual request for innovation applications is open to all faculty, staff, students, and trainees across the Duke campus who have ideas on how we remain an innovating health system.

DIHI is excited to announce the next emerging ideas and innovation funding cycle for demonstration pilots. Proposed projects should address actual and important problems encountered by care providers, patients and their loved ones in the Duke University Health System (DUHS), and represent urgent health challenges nationally. For the upcoming funding cycle, DIHI is specifically interested in the following:

  1. Population Health and Analytics
  2. Building Resilience and well-being
  3. Novel Patient Interactions (engagement, education & experience)
  4. Team-based and new care models
  5. Optimizing Patient Flow
  6. Enhanced transitions of care

The RFA will be open for submissions on August 28, 2017 and applications are due by 5 pm on October 6, 2017. If the DIHI team can be of any assistance in the formulation of ideas or connections, please contact Suresh Balu (suresh.balu@duke.edu) or Krista Whalen (krista.whalen@duke.edu).

We look forward to your innovative solutions.

Additional information about the RFA and the proposal template can be found here:  2018 DIHI RFA & Proposal Template

Application is available here using access code DIHI

Apply here

Duke MEDx

Funding Opportunities

Note: All of the following RFPs have passed their deadlines

Call for proposals from the Kaganov Research Initiative in Pulmonary Medicine and Engineering – Submissions are due September 14, 2017

MEDx is pleased to announce a call for proposals from the Kaganov Research Initiative in Pulmonary Medicine and Engineering. This intent of this Initiative, supported by a generous gift from Dr. Alan and Mrs. Carol Kaganov, is to build robust collaborations between engineers and physicians to conduct research that focuses directly on or has relevance to lung function and diseases, especially pulmonary fibrosis.

The Kaganov Research Initiative has the following goals:

  • To improve our understanding of disease mechanisms,
  • enhance diagnosis,
  • create more effective treatments, and
  • ultimately find pathways to cure idiopathic pulmonary fibrosis (IPF) and other lung diseases.

MEDx anticipates awarding 3 to 5 grants that range in amount up to $150,000 in direct costs (no indirect costs are allowed). The term of the award is 1 year. While the intent of these grants is to position investigators to be successful in attaining external support, extremely promising work may be invited to request a second round of funding for additional research.

Proposals should describe cross-disciplinary scientific research on lung diseases or lung function, and particularly idiopathic pulmonary fibrosis (IPF). Research on relevant basic biomedical questions, development of enhanced understanding of disease mechanism, the development of therapies, diagnostics or devices, clinical research/trials (excluding Phase 2 or beyond), epidemiological, and/or community-based studies is within scope. Population health improvement projects should demonstrate significant stakeholder involvement to advance applicability of the results to broader practice patterns, clinical guidelines, and other applications.

View the RFA for full proposal scope, eligibility, requirements, and submission instructions.

Deadline

  • Application Submission Deadline:  September 14, 2017
  • The awardees will present a brief talk describing the problem to be addressed and the research objectives at the Kaganov Symposium, which is tentatively scheduled for October 20, 2017 (watch for announcements on the MEDx website).

Eligibility

  • Proposals must be submitted by Duke regular rank faculty and comply with the Duke University Policy on PI Status in the Duke Faculty Handbook.
  • Proposals must represent a collaboration between a faculty member with an appointment in the Pratt School of Engineering and a faculty member with an appointment in the School of Medicine.
  • The co-PIs cannot have primary appointments in the same School and priority will be given to applications that include one or both PIs with a primary appointment in Medicine or Pratt.
  • Because of the focus of this funding opportunity, the applicants are encouraged to have physicians or scientists with lung disease expertise as part of the collaborative team.
  • More than one proposal may be submitted per faculty member acting as PI, but the faculty member is only eligible to receive one award as PI during a given funding cycle.

Application Submission

Duke MEDx uses the MyResearchProposal online application software to submit applications.

  • Apply Here, click on “Create New User” (or log in if you already have an account). Proposals must be submitted to the system by only one of the Principal Investigators.
  • A step-by-step user’s guide for applying via the CTSI MyResearchProposal software is available – here.
  • Enter Access Code ‘MEDX’ then select the “Kaganov Initiative 2017-2018” funding opportunity and follow the instructions.

More Information

For additional information on this funding opportunity, please contact Donna Crenshaw, PhD MHA, or Brittany Ploss, MSc BSE.

CFAR/MEDx Proposal – Proposal deadline has passed.

The Duke Center for AIDS Research has partnered with MEDx to provide funding of up to $60,000 Direct Costs for one year pilot projects.

The proposal must represent a collaboration between faculty of School of Medicine and School of Engineering, and address an NIH HIV/AIDS Research Priority. Click here for information and details on how to apply.

Proposals are due 5pm, May 1, 2017 and will be awarded in June 2017. Instructions for proposal preparation and submission may be found here.

Please feel free to contact the CFAR Development Core (herman.staats@duke.edu) and/or MEDx (donna.crenshaw@duke.edu) with any questions.

Call for SMIF SUUP Proposals – Proposal deadline has passed.

The SMIF Undergraduate User Program (SUUP), Duke University Shared Materials Instrumentation Facility (SMIF)

 The Support of Undergraduate Student Fabrication in the SMIF Cleanroom and

Operation of Characterization and Imaging Instruments in SMIF

Organized by:

Dr. Nan Jokerst, Dr. Mark Walters

Dr. Richard Fair, Dr. Adrienne Stiff-Roberts, Dr. Martin Brooke

The Pratt School of Engineering

The Lord Foundation has provided funding to continue the SMIF Undergraduate User Program (SUUP).  This program provides a hands-on undergraduate research experience at Duke University to enable undergraduate students to access the Duke University cleanroom and materials characterization shared facility, called the Shared Materials Instrumentation Facility (SMIF).   These funds will support undergraduates in the hands-on fabrication and measurement of materials, structures, and devices in SMIF.

SMIF is a shared, fee-based facility that has cleanroom fabrication and materials and device characterization capabilities.  Users are trained by the permanent, professional SMIF Staff, and, after training, the users are certified to use the equipment on their own. .

The very best possible learning experiences for students involve the design, hands-on fabrication/creation, and test of their research projects. The SUUP funds will be used to support the SMIF fees of undergraduate students who are working with Duke Faculty in areas that can utilize SMIF.  The cleanroom, characterization and imaging facilities in SMIF are extensive; a complete list of capabilities, the training instructions and schedules, and the fee schedule can be accessed at http://smif.pratt.duke.edu.

Since the proposed program will involve an extensive design/build/test approach, to give the students the most complete “idea to implementation” experience, this program will be limited to undergraduate research students who commit to at least 2 academic semesters of research with a faculty member or who are a Pratt Research Fellow.  The SMIF training takes from 1-5 weeks, depending upon the number of tools accessed, thus, at least two academic semesters are recommended for students to engage in a meaningful experience that includes SMIF use.

Proposals from students and faculty, limited to 1 page in length, will be reviewed by the SUUP organizers (listed above), and proposals will be funded based upon the available funds and the projected expenditures.  Proposals will be judged based upon the impact that SMIF will have on the project, and the quality of the proposal, with preference given to multidisciplinary projects. A balance between cleanroom and characterization and imaging facilities will also be considered.

Proposals should be submitted to Dr. Walters, Director of SMIF, via email at mark.walters@duke.edu.  The proposal deadline is January 27, 2017.  Proposals received will be evaluated as a group and awards will be announced by the end of January 2017.  Proposals received after January 27th will be evaluated on a rolling basis, and awarded as funds permit.

Proposals will be funded up to a maximum of $500 per month in SMIF user fee expenses through June 30th, 2017.  Please include a projected expenditure rate as a function of month through the duration of the proposal.   The SMIF fees have a monthly cap that enables the SMIF users to project what the maximum fees of any user are per month.  Thus, the undergraduate researchers and the proposers of this proposal will be able to estimate the usage levels, and offer grants to the students accordingly.  Current SMIF user fee rates can be found at http://smif.pratt.duke.edu/user-fees-and-billing.

MEDx Biomedical Research RFP – Proposal deadline has passed.

This MEDx funding announcement will award funds of up to $50,000 for novel pilot projects that investigate a basic biomedical question or for the development of tools or technologies that enable biomedical discovery. The pilot projects must be collaborations between faculty members in the Pratt School of Engineering and the School of Medicine.

Beyond achieving new partnerships between the School of Medicine and Pratt, this opportunity should catalyze research or development that will lead to follow-on funding, which can take various forms (e.g. NIH, CTSI, or Coulter grant, SBIR).

MEDx is joined in funding this successful applications by the Departments of Pathology and Biostatistics & Bioinformatics and the Duke Cardiovascular Research Center from the School of Medicine, and the Departments of Mechanical Engineering & Material Sciences and Biomedical Engineering in the Pratt School of Engineering.

Deadline

  • Application submission deadline is 11:50 pm on Thursday, January 19, 2017.

Eligibility

  • Proposed projects must have a lead investigator from each of the Schools of Medicine and Engineering. The project lead may be from either School.
  • Existing collaborators may compete, but the proposed project must be in a new area of research.
  • Successful proposals will be awarded up to $50,000. The funding may be used to support fellows, post docs and/or students but not faculty effort or travel. Indirect costs are not supported.
  • Due Date: Proposals must be received by 11:59 pm on Thursday, January 19, 2017.
    Award Notice: Target is March 15, 2017.
    Project Start Date: Target is March 27, 2017.
  • Period of Performance: Projects must propose a realistic end date. A 12-month or shorter project period is desirable, but longer periods of performance will be considered if justified.
  • View the RFA for full proposal instructions.

Application Submission

MEDx uses the MyResearchProposal online application software to submit applications. To apply:

  • To apply, visit http://bit.ly/myresearchproposal, click on “Create New User” (or log in if you already have an account). Proposals may be submitted under either of the Co-Principal Investigator’s name.
  • A step-by-step user’s guide for applying via the DTMI MyResearchProposal software is available – here.
  • Enter Access Code ‘MEDX’ then select the “MEDx Pilot Project 2017” funding opportunity and follow the instructions.

For questions, email Julia Walker (Julia.s.walker@duke.edu) or attend MEDx office hours (i.e. the MEDx Café). See the MEDx Café calendar for dates, time and location.

MEDx is leading a syndicate comprising the School of Medicine, the Duke Cardiovascular Research Center, and the Departments of Pathology, Biostatistics and Bioinformatics, Mechanical Engineering and Material Science, and Biomedical Engineering that will award funding to promote the formation of new collaborations between faculty in the Schools of Medicine and Engineering.

Proposals should address basic research in the biomedical sciences or the development of tools or technologies that enable or enhance biomedical discovery.

Beyond achieving new partnerships between the School of Medicine and Pratt, this opportunity should catalyze research or development that will lead to follow-on funding, which can take various forms (e.g. NIH, CTSI, or Coulter grant, SBIR).

More about the Application

  • Faculty co-investigators from the Schools of Medicine and Engineering should propose a new collaboration to conduct novel research into a basic science question or develop a novel technology or device with utility for research or medicine. The project lead may be from either School.
  • Existing collaborators may compete, but the proposed project must be in a new area of research.
  • Successful proposals will be awarded up to $50,000. The funding may be used to support fellows, post docs and/or students but not faculty effort or travel. Indirect costs are not supported.
  • Due Date: Proposals must be received by 11:59 pm on Thursday, January 19, 2017.
    Award Notice: Target is March 15, 2017.
    Project Start Date: Target is March 27, 2017.
  • Period of Performance: Projects must propose a realistic end date. A 12-month or shorter project period is desirable, but longer periods of performance will be considered if justified.
  • View the RFA for full proposal instructions.

MEDx Colloquia Series – Proposal deadline has passed.

MEDx is pleased to offer support for interdisciplinary colloquia that bring together physicians, engineers, computer scientists, data analysts, and basic and/or clinical researchers with a common desire to combine the elements of medicine and engineering to solve complex problems and inspire innovation. Proposal deadline for 2015-1016 has passed.
Learn more  See 2015-2016 MEDx Colloquia funding recipients

MEDx Call for Pratt/SOM Proposals for Pilot Research Projects in Diagnostics and Devices – Proposal deadline has passed.

This request for proposals is targeted to enhance collaborations between the School of Medicine and Pratt facuty in the area of diagnostics and devices.  MEDx is leading a syndicate of highly interdisciplinary partners – The Clinical and Translational Science Award (CTSA), the Duke Institute for Health Innovation (DIHI), the Departments of Medicine, Surgery, Neurosurgery, Orthopedic Surgey and Mechanical Engineering and Materials Science – to fund these pilot projects. The goal of this opportunity is to catalyze the development of collaborative proposals that will lead to external funding within 12 months of completion of this project. Proposal deadline for 2015-2016 has passed.
Learn more

Seed Funding for Collaborative Quantitative Approaches – Proposal deadline has passed.

The Office of the Vice Provost for Research, MEDx and other Duke entities are co-sponsoring a seed funding program to support “Collaborative Quantitative Approaches to Problems in the Basic and Clinical Sciences.” Research collaborations between campus and School of Medicine faculty are eligible for up to $50,000 in support. Proposal deadline for 2015-2016 has passed.
Learn more

MedBlue

Our application period is currently CLOSED.  An announcement, as to funding of the proposals submitted for the September 15, 2017 deadline, will be forthcoming by February 1, 2018.  

MedBlue Incubator typically invites members of the Duke University community to apply for funding and business support once or twice each year. A request for proposals will be sent out in advance.

Applications are thoroughly reviewed by the Technology Review Committee, which selects the most promising medical technology opportunities for support by the MedBlue Incubator program. The committee makes its recommendations for funding to the MedBlue board of directors.

 NOTE:  Funding is intended for development of the technology in a company setting (including for formation of a company, if not already formed), and is not intended for use by an investigator as research funds for the investigator’s lab.

When you apply, the Technology Review Committee evaluates proposals* based on a number of criteria, which include:

  • Brief introduction of overall scope
  • Innovation/robustness of technology
    • Is it novel, commercially attractive and tractable?
  • Commercial potential
    • Is there an unmet medical need? Market size? More than one substantial medical application?
  • Development status
    • Is there a prototype, screening method for identifying candidates, or functional assays to further develop candidates?
  • Would MedBlue investment enable the attainment of a key development milestone?
    • Does the proposal identify key milestones, technology used and cost to get there?
  • Potential sources for raising additional funding, such as government grants (e.g. SBIR/STTR, NC Bio)
    • Is this technology appealing to investors and commercial partners? Proposals should identify some deals made in this area of technology, if possible. Alternatively, list companies developing products in this space.
  • Intellectual property
    • What are the status and prospects of IP filings?
  • Yearly budget up to $75,000

*Note: There is no specific format for the application other than to address the above-listed criteria.  Typical application length is from 3-7 pages.  An application should be submitted by email as a pdf.

Outside funding opportunities

NC Biotech

Center Funding

Biotechnology Center grant and loan programs support academic research, company development, and community networking to grow the life sciences in North Carolina.

See all available funding

TaNeDS Global 2018

Daiichi Sankyo’s open competition grant program

TaNeDS program provides close partnership between you and scientists in Daiichi Sankyo to tackle unmet medical needs.

The program is open to principal investigators affiliated with research institution in academia and small biotech located in Europe and the east coast of the United States.
The Deadline of Submission is February 19, 2018

What is TaNeDS?

TaNeDS (Take a New Challenge for Drug diScovery) is Daiichi Sankyo’s open competition grant program. To help realize our corporate philosophy – “Passion for Innovation. Compassion for Patients.” –this program serves as an interactive platform that gathers and nurtures the wisdom of researchers from diverse scientific backgrounds.

Learn More